ArticlePloS one2014

Novel benzoxazine-based aglycones block glucose uptake in vivo by inhibiting glycosidases.

Hanumantharayappa Bharathkumar et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.